Based on Your Reading:
Get a Mesothelioma Treatment Guide
Find a Top Mesothelioma Doctor
Access Help Paying for Treatment
Shukla Research Lab
Table Of Contents
The Shukla Research Lab at the University of Vermont is dedicated to understanding how asbestos exposure causes diseases, such as mesothelioma and lung cancer, and discovering therapies to treat these conditions.
Written by Tim Povtak | Edited By Walter Pacheco | Last Update: September 19, 2024
"Most helpful, steered us in the right direction for treatment. Great source of information and support, the Center followed through on every one of our requests...." see more
Elaine C.
Mesothelioma Patient
"Because of their guidance, I was able to navigate getting my mother into MD Anderson when her case got put aside by mistake in all the COVID-19 craziness. Vanes...." see more
Deanna B.
Daughter of a Mesothelioma Patient
"Hearing the news about my mother's diagnosis was heartbreaking. I felt lost, I didn't know how I could help or where to seek the best medical care. I started re...." see more
Danielle W.
Daughter of a Mesothelioma Patient
"My son Carlos was diagnosed with this terrible and unknown disease a few months ago. Thank God we found The Mesothelioma Center along the way, and Vanessa Blanc...." see more
Martha M.
Mother of a Mesothelioma Patient
"Extremely communicative and helped my dad get an appointment with one of the top centers in Philadelphia. I'm so grateful for this center. They assisted with in...." see more
Sunni H.
Loved One of a Mesothelioma Patient
"Danielle DiPietro was an invaluable resource for me. Her suggestions and recommendations guided us towards stellar practitioners in our area. Without her advoca...." see more
Deborah C.
Spouse of a Mesothelioma Patient
"I was very grateful and appreciative of Dr. Smart from The Mesothelioma Center. She was very helpful to my husband and me. She educated and walked us through th...." see more
Kimberlin C.
Spouse of a Mesothelioma Patient
"In January of 2016, my husband was diagnosed with peritoneal mesothelioma. Our first reaction was: what is this and what can we do? He was diagnosed by an oncol...." see more
Gloria R.
Spouse of a Mesothelioma Patient
Written by Tim Povtak | Edited By Walter Pacheco | Last Update: September 19, 2024
The Shukla Research Lab (SRL) at the University of Vermont’s Larner College of Medicine aims to understand how asbestos causes disease and develop diagnostic and therapeutic approaches for asbestos-related diseases.
Part of the research at SRL involves studying the early detection of mesothelioma through biomarkers, which are unique compounds that help doctors identify diseases.
SRL also researches how asbestos fibers cause mesothelioma cancer and how inflammation affects mesothelioma development.
SRL is part of the Department of Pathology and laboratory medicine at Larner College of Medicine. In addition to promoting research and educating future pathologists, the pathology department also offers clinical services such as diagnosing biopsy samples.
Research conducted at SRL may lead to earlier mesothelioma diagnoses and better treatment. They’re even working on ways to prevent mesothelioma before it even has a chance to develop.
Leadership and Funding
The lab is led by Arti Shukla, Ph.D., who also serves as an associate professor in the pathology department of the University of Vermont’s Larner College of Medicine.
In 2020, Dr. Shukla published breakthrough research on extracellular vesicle and particle proteins that can serve as reliable biomarkers for cancer detection and determining cancer type.
Shukla earned her degrees in biochemistry from Banaras Hindu University in India and held a post-doctoral research position at the University of Michigan. She was a visiting scientist at the University of Vermont before becoming a research assistant professor in the university’s pathology department.
Shukla has earned numerous awards and honors, including awards from the Vermont Cancer Center and invitations to peer-review mesothelioma research.
Since 2002, Shukla has published dozens of studies on asbestos and mesothelioma cancer in peer-reviewed medical journals.
Part of SRL’s research is funded by the U.S. Department of Defense, the National Institute of Environmental Health Sciences and the National Institutes of Health.
SRL is among the few research centers investigating how asbestos causes mesothelioma. Other research centers, such as the Vaccine and Immunotherapy Center and the Pacific Meso Center, focus their research on improving therapies to treat mesothelioma.
Research on Mesothelioma
SRL’s mesothelioma research involves understanding how asbestos causes cancer, biomarkers for early diagnosis and targeted therapies for treatment.
SRL’s team has focused on:
- Cell signaling pathways
- Inflammasomes
- Exosomes
Cell signaling pathways are the chain reactions triggered by asbestos fibers that lead to mesothelioma.
Understanding these pathways might help researchers develop drugs to prevent mesothelioma from ever developing in the first place.
Inflammasomes are a collection of proteins that detect foreign invaders — such as asbestos fibers — and activate inflammatory parts of the immune system to attack the invaders.
Asbestos appears to over-activate inflammasomes, leading to uncontrolled inflammation that contributes to the development of mesothelioma. Understanding inflammasomes may help researchers learn how to control inflammation contributing to mesothelioma growth.
Exosomes are fluid-filled sacs released from cells that are involved in cell-to-cell communication. These sacs comprise proteins, fats and nucleic acids (the building blocks of DNA and RNA).
Understanding exosomes may lead to identifying a biomarker to diagnose mesothelioma in its earliest stages.
In 2018, SRL’s exosome study was published in The FASEB Journal. The study was the first to show asbestos exposure alters exosomes in ways that cause genetic damage in mesothelial cells.
SRL’s research is filling knowledge gaps in our understanding of exactly how asbestos fibers cause mesothelioma and how we can better diagnose and treat asbestos-related diseases.
This Page Contains 7 Cited Articles
The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.
- Hoshino, A. et al. (2020, August 13). Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Retrieved from https://pubmed.ncbi.nlm.nih.gov/32795414/
- University of Vermont. (n.d.). Shukla Research Lab. Retrieved from https://www.med.uvm.edu/pathology/shukla-lab_new
- University of Vermont. (n.d.). Shukla Research Highlights How Asbestos Causes Lung Disease Mesothelioma. Retrieved from https://www.med.uvm.edu/pathology/news/2018/03/27/shukla_research_highlights_how_asbestos_causes_lung_disease_mesothelioma
- Willms, E. et al. (2016). Cells release subpopulations of exosomes with distinct molecular and biological properties. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773763/
- Edgar, J.R. (2016). Q&A: What are exosomes, exactly? Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906597/
- Nature. (n.d.). Inflammasome. Retrieved from https://www.nature.com/subjects/inflammasome
- Munson, P. et al. (2018). Exosomes from asbestos-exposed cells modulate gene expression in mesothelial cells. Retrieved from https://www.fasebj.org/doi/10.1096/fj.201701291RR
Get Your Free Mesothelioma Treatment Guide
Watch Our Free Mesothelioma Webinars
Find Active Mesothelioma Clinical Trials
